Theranostic laser system for multi-function drug activation and monitoring

Presented in: SPIE BIOS 2022

Authors: Robert Perttilä, Visa Kaivosoja, Elias Kokko, Zoe Ylöniemi, Lasse Orsila, Modulight Corporation (Finland), Tampere Univ. Hospital (Finland); Timo Tanila, Petteri Uusimaa, Modulight Corporation (Finland)

Here we present novel cloud-connected theranostic medical laser platform specifically designed for activating and simultaneously monitoring multi-component oncological treatment processes. It may incorporate multiple wavelengths for inducing therapeutic effect or monitoring treatment in real-time. The same low-invasive optical probers can be used for treatment and monitoring. We believe that this theranostic laser platform will allow clinicians to develop improved treatment outcomes for cancer patients that may be based on machine learning and AI in the future.

 

 

Read the article here